Dr. Martens (LON:DOCS) Trading Up 25.8% - Time to Buy?

Shares of Dr. Martens plc (LON:DOCS - Get Free Report) were up 25.8% during trading on Thursday . The stock traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). Approximately 8,364,149 shares were traded during mid-day trading, an increase of 271% from the average daily volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($94.75) to GBX 6,000 ($81.21) and set a "sector perform" rating on the stock in a report on Monday, May 19th.

Dr. Martens Trading Up 8.7%

The company has a market cap of £795.54 million, a PE ratio of 11.62, a P/E/G ratio of 6.40 and a beta of 0.11. The stock's 50 day moving average is GBX 55.34 and its 200-day moving average is GBX 62.91. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, sell-side analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current year.

Dr. Martens Cuts Dividend

The firm also recently declared a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's payout ratio is 42.53%.

Insider Activity at Dr. Martens

In other news, insider Giles Wilson acquired 32,640 shares of the business's stock in a transaction on Tuesday, March 25th. The shares were acquired at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,857.07). Insiders have acquired a total of 33,206 shares of company stock valued at $1,792,771 over the last 90 days. 4.36% of the stock is owned by corporate insiders.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.